Mirae Asset Global ETFs Holdings’s Xeris Biopharma Holdings XERS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$428K	Buy	73,870 +2,559	+4%	+$17K	﹤0.01%	1963
2025 Q4	$560K	Sell	71,311 -20	-0%	-$157	﹤0.01%	1833
2025 Q3	$581K	Sell	71,331 -10,807	-13%	-$71.8K	﹤0.01%	1798
2025 Q2	$384K	Sell	82,138 -1,844	-2%	-$8.45K	﹤0.01%	1945
2025 Q1	$461K	Buy	83,982 +3,594	+4%	+$14.5K	﹤0.01%	1915
2024 Q4	$273K	Buy	80,388 +3,447	+4%	+$11.1K	﹤0.01%	2233
2024 Q3	$219K	Buy	76,941 +10,234	+15%	+$26.3K	﹤0.01%	2333
2024 Q2	$150K	Buy	+66,707	New	+$134K	﹤0.01%	2395

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's XERS Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Xeris Biopharma Holdings (XERS) stake by 3.6% in Q1 2026, buying an estimated $17K and bringing the position to 73,870 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #1963.

Mirae Asset Global ETFs Holdings first reported a position in XERS in Q2 2024 and has held it in 8 quarters since. The position peaked at $581K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

Mirae Asset Global ETFs Holdings held 73,870 shares of Xeris Biopharma Holdings worth $428K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 2,559 Xeris Biopharma Holdings shares in Q1 2026, an estimated $17K.
Xeris Biopharma Holdings made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1963 holding.
Mirae Asset Global ETFs Holdings first reported a position in Xeris Biopharma Holdings in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Xeris Biopharma Holdings position peaked at $581K in Q3 2025.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.